Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Edgewise Therapeutics (EWTX) granted equity inducement awards to four new non-executive employees on August 31, 2026 under its 2024 Inducement Equity Incentive Plan.

Rhea-AI Summary

Edgewise Therapeutics (EWTX) granted equity inducement awards to four new non-executive employees on August 31, 2026 under its 2024 Inducement Equity Incentive Plan. The awards consist of stock options to purchase a total of 21,000 shares and restricted stock units (RSUs) covering 10,501 shares of common stock.

The stock options have an exercise price of $41.77 per share, equal to the closing price on the grant date. Each option vests 25% on the employee’s one-year employment anniversary, with the remaining 75% vesting in equal monthly installments over the following three years, subject to continued service. Each RSU award vests in four equal annual installments on the first through fourth anniversaries of the grant date, also subject to continued service. The grants are structured as inducement awards in accordance with Nasdaq Listing Rule 5635(c)(4).

News Explained

The August 31, 2026 awards create a contingent path for 21,000 option shares and 10,501 RSU shares to enter Edgewise’s common stock, which could change existing holders’ ownership percentages; vesting runs over one to four years and requires continued service.

Market Context

Insider records showed 29,806 shares sold and zero bought over the analyzed period. That context add...

Analysis

Insider records showed 29,806 shares sold and zero bought over the analyzed period. That context adds a governance signal to the inducement-grant announcement; future Form 4 activity and award-related share issuance remain relevant watch items.

Key Figures

Grant Date: August 31, 2026 New Employees: 4 employees Stock Options: 21,000 shares +5 more

8 metrics

Grant Date August 31, 2026 Inducement awards

New Employees 4 employees Recipients of inducement awards

Stock Options 21,000 shares Total inducement stock options

Restricted Stock Units 10,501 shares Total inducement RSU awards

Exercise Price $41.77 per share Equal to closing price on the grant date

Initial Option Vesting 25% Vests on the one-year anniversary of each employee's start date

Monthly Option Vesting 1/48th Additional shares vest monthly after the initial one-year vesting

RSU Vesting 1/4 per year Vests on the first through fourth yearly anniversaries

Historical Context

5 past events · Latest: Aug 24 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 24	Clinical presentation notice	Neutral	+1.2%	Late-breaking ESC presentation announcement for CIRRUS-HCM Phase 2 top-line data
Aug 06	Second-quarter earnings	Neutral	-1.3%	Second-quarter results included Servier transaction and a larger year-over-year net loss
Jul 13	Business acquisition completion	Positive	-9.1%	Servier completed acquisition of muscular dystrophy business for up to $2.65 billion
Jul 13	Asset sale completion	Positive	-9.1%	Edgewise completed sevasemten sale with $1.55 billion upfront consideration
Jul 01	Inducement grant announcement	Neutral	-3.6%	Inducement options for 16,500 shares at $40.63 per share

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Four of five prior news reactions diverged from the neutral or positive tone of the associated event descriptions, including two July 13 announcements.

Key Terms

inducement stock options, restricted stock units, nasdaq listing rule 5635(c)(4)

3 terms

inducement stock options financial

"granted inducement stock options to purchase a total of 21,000 shares"

Inducement stock options are grants of the company’s stock rights given to recruit or retain a specific executive or employee, often as a signing bonus instead of cash. Investors care because these awards can increase the total shares outstanding and dilute existing ownership, alter future reported expenses, and signal how the company is paying for talent; think of them as a hiring incentive paid in future company pieces rather than immediate money.

restricted stock units financial

"awards of inducement restricted stock units covering a total of 10,501 shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOULDER, Colo., Sept. 2, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today announced that on August 31, 2026, Edgewise granted inducement stock options to purchase a total of 21,000 shares of Edgewise's common stock and awards of inducement restricted stock units (each, an "RSU award") covering a total of 10,501 shares of Edgewise's common stock to 4 new non-executive employees in connection with the commencement of their employment, pursuant to Edgewise's 2024 Inducement Equity Incentive Plan (the "Inducement Plan"). 

Each inducement stock option has an exercise price of $41.77 per share, which is equal to the closing price of a share of Edgewise common stock on the grant date, and shall vest as follows: 25% of the shares subject to such inducement stock option shall vest on the one year anniversary of the start date of each employee, and an additional one forty-eighth (1/48th) of the shares subject to such inducement stock option shall vest monthly thereafter, subject to the employee's continued service.

Each inducement RSU award shall vest as follows: one-fourth (1/4th) of the shares subject to each inducement RSU award shall vest on the first, second, third and fourth yearly anniversaries of the grant date, subject to the employee's continued service.

Each inducement award is subject to the terms of the Inducement Plan and related forms of agreements, and were granted as inducements material to these employees to enter into employment with Edgewise in accordance with Nasdaq Listing Rule 5635(c)(4). 

About Edgewise Therapeutics                                                              

Edgewise Therapeutics is a leading biopharmaceutical company focused on developing innovative therapies for serious cardiovascular and cardiometabolic diseases. Leveraging its expertise in integrated muscle physiology and small molecule drug development, Edgewise is advancing a cardiovascular pipeline targeting significant unmet needs, including hypertrophic cardiomyopathy and heart failure. To learn more, go to edgewisetx.com or follow Edgewise on LinkedIn, X, Facebook and Instagram.

This press release contains hyperlinks to information that is not deemed to be incorporated by reference into this press release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302866448.html

SOURCE Edgewise Therapeutics

FAQ

What equity inducement awards did Edgewise Therapeutics (EWTX) grant on August 31, 2026?

Edgewise Therapeutics granted inducement stock options to purchase 21,000 shares and inducement restricted stock unit awards covering 10,501 shares of common stock to four new non-executive employees under its 2024 Inducement Equity Incentive Plan.

What is the exercise price of the new Edgewise Therapeutics (EWTX) inducement stock options?

The inducement stock options have an exercise price of $41.77 per share, which equals the closing price of Edgewise Therapeutics common stock on the August 31, 2026 grant date.

How do the Edgewise Therapeutics (EWTX) inducement stock options vest for new employees?

Each inducement stock option vests 25% on the one-year anniversary of the employee’s start date. The remaining 75% vests in equal monthly installments (1/48th of the total) over the next three years, subject to continued service.

What is the vesting schedule for the Edgewise Therapeutics (EWTX) inducement RSU awards?

Each inducement RSU award vests in four equal installments: one-fourth of the shares vest on each of the first, second, third and fourth anniversaries of the grant date, provided the employee continues to serve the company.

Under what plan and Nasdaq rule were the Edgewise Therapeutics (EWTX) inducement grants made?

The inducement stock options and RSU awards were granted under Edgewise’s 2024 Inducement Equity Incentive Plan as inducements material to employment, in accordance with Nasdaq Listing Rule 5635(c)(4).